Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells

Published:2018-01 Issue:1 Volume:29 Page:29-39
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Fang Chiung-Yao,Chen Jeng-Sheng,Chang Shun-Kai,Shen Cheng-Huang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference40 articles.

1. Bladder cancer incidence and mortality: a global overview and recent trends;Antoni;Eur Urol,2017

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Bladder cancer;Kaufman;Lancet,2009

4. Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up;Bellmunt;Ann Oncol,2014

5. Advanced bladder cancer: new agents and new approaches. A review;Volpe;Urol Oncol,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageing;Biochemical Society Transactions;2024-06-28

2. Reversine inhibits proliferation and induces apoptosis of human osteosarcoma cells through targeting MEK1;Journal of Bone Oncology;2024-06

3. Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells;Blood Cells, Molecules, and Diseases;2024-01

4. Reversine ameliorates hallmarks of cellular senescence in human skeletal myoblasts via reactivation of autophagy;Aging Cell;2023-01-10

5. Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2;Bioengineered;2021-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3